|
|
|
|
 |
|
SENSEX
|
 |
-393.09
|
-0.55%
|
|
71633.06
|
|
|
|
NIFTY
|
|
-125.55
|
-0.58%
|
|
21585.25
|
|
|
|
Nasdaq
|
 |
13.77
|
0.09%
|
|
14524.07
|
|
|
|
Nikkei 225
|
|
89.13
|
0.27%
|
|
33377.42
|
|
|
|
FTSE 100
|
|
-33.50
|
-0.43%
|
|
7689.60
|
|
|
 |
|
|
|
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Reddy's Laboratories Ltd.
|
|
|
|
05-01-2024
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
|
|
05-01-2024
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
|
|
|
|
|
04-01-2024
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
|
|
04-01-2024
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 03, 2024, titled "ￂﾬￂﾬDr. Reddy's announces the acquisition of MenoLabsￂﾮ, a leading women s health and dietary supplements portfolio of brands". |
|
|
|
|
|
04-01-2024
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 03, 2024, titled "ￂﾬￂﾬDr. Reddy's announces the acquisition of MenoLabsￂﾮ, a leading women s health and dietary supplements portfolio of brands" |
|
|
|
|
|
03-01-2024
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 03, 2024, titled "ￂﾬￂﾬDr. Reddy's announces the acquisition of MenoLabsￂﾮ, a leading women s health and dietary supplements portfolio of brands". |
|
|
|
|
|
01-01-2024
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
|
|
|
|
|
29-12-2023
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange about Acquisition of securities by a wholly-owned step-down subsidiary company |
|
|
|
|
|
29-12-2023
|
|
|
|
| Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company. |
|
|
|
|
|
29-12-2023
|
|
|
|
| DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|